Cationic gold nanoparticles elicit mitochondrial dysfunction: a multi-omics study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 03 2019
Historique:
received: 11 09 2018
accepted: 19 02 2019
entrez: 15 3 2019
pubmed: 15 3 2019
medline: 2 10 2020
Statut: epublish

Résumé

Systems biology is increasingly being applied in nanosafety research for observing and predicting the biological perturbations inflicted by exposure to nanoparticles (NPs). In the present study, we used a combined transcriptomics and proteomics approach to assess the responses of human monocytic cells to Au-NPs of two different sizes with three different surface functional groups, i.e., alkyl ammonium bromide, alkyl sodium carboxylate, or poly(ethylene glycol) (PEG)-terminated Au-NPs. Cytotoxicity screening using THP-1 cells revealed a pronounced cytotoxicity for the ammonium-terminated Au-NPs, while no cell death was seen after exposure to the carboxylated or PEG-modified Au-NPs. Moreover, Au-NR3+ NPs, but not the Au-COOH NPs, were found to trigger dose-dependent lethality in vivo in the model organism, Caenorhabditis elegans. RNA sequencing combined with mass spectrometry-based proteomics predicted that the ammonium-modified Au-NPs elicited mitochondrial dysfunction. The latter results were validated by using an array of assays to monitor mitochondrial function. Au-NR3+ NPs were localized in mitochondria of THP-1 cells. Moreover, the cationic Au-NPs triggered autophagy in macrophage-like RFP-GFP-LC3 reporter cells, and cell death was aggravated upon inhibition of autophagy. Taken together, these studies have disclosed mitochondria-dependent effects of cationic Au-NPs resulting in the rapid demise of the cells.

Identifiants

pubmed: 30867451
doi: 10.1038/s41598-019-40579-6
pii: 10.1038/s41598-019-40579-6
pmc: PMC6416392
doi:

Substances chimiques

Ammonium Compounds 0
Cations 0
Proteome 0
Gold 7440-57-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4366

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM118188
Pays : United States

Références

Nat Nanotechnol. 2011 Jan;6(1):39-44
pubmed: 21170037
PLoS One. 2016 Nov 23;11(11):e0166816
pubmed: 27880838
J Exp Med. 1998 Sep 7;188(5):979-84
pubmed: 9730899
Sci Rep. 2015 Sep 23;5:14361
pubmed: 26394839
Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56
pubmed: 26527722
Nat Rev Mol Cell Biol. 2008 Jul;9(7):532-42
pubmed: 18568041
Nanoscale. 2015 Jan 28;7(4):1349-62
pubmed: 25491924
Nat Protoc. 2012 Apr 05;7(5):813-28
pubmed: 22481528
Nat Commun. 2013;4:2726
pubmed: 24225442
J Biol Chem. 2010 Apr 2;285(14):10850-61
pubmed: 20123989
Nat Commun. 2014;5:3295
pubmed: 24548894
Cell Death Dis. 2011 May 19;2:e159
pubmed: 21593791
Sci Rep. 2018 Apr 27;8(1):6668
pubmed: 29703973
Genome Res. 2011 Jul;21(7):1160-7
pubmed: 21543516
Mol Cell Proteomics. 2013 Aug;12(8):2324-31
pubmed: 23589346
Acta Biomater. 2017 Apr 15;53:598-609
pubmed: 28161575
Protein Cell. 2013 Aug;4(8):582-90
pubmed: 23828195
Proteomics. 2015 Aug;15(15):2597-601
pubmed: 25921073
ACS Nano. 2016 Nov 22;10(11):10471-10479
pubmed: 27797479
EMBO J. 2004 Nov 24;23(23):4679-89
pubmed: 15526035
Part Fibre Toxicol. 2012 Jun 14;9:20
pubmed: 22697169
ACS Nano. 2011 Dec 27;5(12):9354-69
pubmed: 22107733
ACS Nano. 2010 Dec 28;4(12):7481-91
pubmed: 21082814
Nanoscale. 2013 Nov 21;5(22):10868-76
pubmed: 24108393
Cell. 1993 Nov 19;75(4):641-52
pubmed: 8242740
Chem Soc Rev. 2012 Apr 7;41(7):2780-99
pubmed: 22086677
Biomaterials. 2010 Aug;31(23):5996-6003
pubmed: 20466420
ACS Nano. 2012 Oct 23;6(10):8962-9
pubmed: 22998416
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1638-43
pubmed: 18230723
Int J Nanomedicine. 2017 Mar 31;12:2531-2551
pubmed: 28408823
Angew Chem Int Ed Engl. 2014 Feb 10;53(7):1756-89
pubmed: 24421264
Small. 2009 Sep;5(18):2067-76
pubmed: 19642089
Nanotoxicology. 2017 Aug;11(6):809-826
pubmed: 28816564
Hum Mol Genet. 2011 Jan 1;20(1):40-50
pubmed: 20940149
Cell. 2017 Jan 12;168(1-2):224-238.e10
pubmed: 28017329
EMBO Rep. 2002 Jul;3(7):604-9
pubmed: 12101090
Mol Biol Cell. 2001 Aug;12(8):2245-56
pubmed: 11514614
Langmuir. 2004 May 11;20(10):4226-35
pubmed: 15969421
ACS Nano. 2013 Dec 23;7(12):10799-808
pubmed: 24251827
Nanotoxicology. 2011 Dec;5(4):557-67
pubmed: 21142842
ACS Nano. 2011 Nov 22;5(11):8629-39
pubmed: 21974862
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3490-5
pubmed: 24550482
Nat Rev Immunol. 2005 Apr;5(4):331-42
pubmed: 15803152
Cell Metab. 2015 Feb 3;21(2):273-286
pubmed: 25600785
Bioinformatics. 2013 Nov 15;29(22):2943-5
pubmed: 23995393
Langmuir. 2012 Jul 17;28(28):10398-408
pubmed: 22702239
Nature. 2015 May 28;521(7553):525-8
pubmed: 25896323
Toxicol Appl Pharmacol. 2016 May 15;299:101-11
pubmed: 26721310
Anal Sci. 2012;28(12):1139-44
pubmed: 23232232
ACS Nano. 2016 Feb 23;10(2):2103-12
pubmed: 26751094
Nature. 2016 Oct 6;538(7623):123-126
pubmed: 27626371
Nano Lett. 2006 Apr;6(4):611-5
pubmed: 16608253
ACS Nano. 2014 Jun 24;8(6):5515-26
pubmed: 24797313
Nanotoxicology. 2016 Aug;10(6):736-48
pubmed: 26647645
Autophagy. 2007 Sep-Oct;3(5):452-60
pubmed: 17534139
Toxicol Sci. 2008 Nov;106(1):5-28
pubmed: 18566021
Sci Rep. 2017 Aug 24;7(1):9284
pubmed: 28839176
Nature. 2017 Mar 16;543(7645):443-446
pubmed: 28241148
ACS Nano. 2014 Mar 25;8(3):2439-55
pubmed: 24517450
J Proteome Res. 2017 Feb 3;16(2):689-697
pubmed: 27973853
Langmuir. 2009 Jun 16;25(12):6683-9
pubmed: 19371042
Small. 2010 Oct 18;6(20):2246-9
pubmed: 20818619
Cell. 2004 Jan 23;116(2):205-19
pubmed: 14744432
Adv Healthc Mater. 2018 Feb;7(4):
pubmed: 29266859
Cell Death Dis. 2017 Jul 27;8(7):e2954
pubmed: 28749469
Small. 2009 Mar;5(6):701-8
pubmed: 19226599
J Clin Invest. 2015 Jan;125(1):25-32
pubmed: 25654547
Toxicol Lett. 2013 Mar 13;217(3):205-16
pubmed: 23246733
Small. 2005 Mar;1(3):325-7
pubmed: 17193451
J Cell Biol. 2010 Sep 6;190(5):881-92
pubmed: 20819940
Curr Top Dev Biol. 2015;114:43-65
pubmed: 26431563
Nature. 2011 Jan 20;469(7330):323-35
pubmed: 21248839
Int J Nanomedicine. 2014 Sep 12;9:4317-30
pubmed: 25246788
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Mol Cell. 2008 Nov 21;32(4):529-39
pubmed: 19026783
EMBO Rep. 2010 Sep;11(9):678-84
pubmed: 20725092
Chem Soc Rev. 2012 Apr 7;41(7):2740-79
pubmed: 22109657
Nature. 2002 Oct 31;419(6910):939-44
pubmed: 12410314
Acc Chem Res. 2013 Mar 19;46(3):733-42
pubmed: 22720979
ACS Nano. 2017 Apr 25;11(4):3597-3613
pubmed: 28345861
J Biol Chem. 2009 Oct 9;284(41):27827-37
pubmed: 19679660
ACS Nano. 2015 Jan 27;9(1):146-63
pubmed: 25530437
Nanotoxicology. 2013 May;7(3):314-22
pubmed: 22394123
ACS Nano. 2016 Nov 22;10(11):10173-10185
pubmed: 27788331
J Phys Chem B. 2009 Aug 13;113(32):11179-85
pubmed: 19606833
Nanoscale. 2011 Feb;3(2):410-20
pubmed: 21229159

Auteurs

Audrey Gallud (A)

Nanosafety & Nanomedicine Laboratory, Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.

Katharina Klöditz (K)

Nanosafety & Nanomedicine Laboratory, Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.

Jimmy Ytterberg (J)

Department of Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.

Nataliya Östberg (N)

Department of Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.

Shintaro Katayama (S)

Department of Biosciences & Nutrition, Karolinska Institutet, 141 83, Huddinge, Sweden.

Tiina Skoog (T)

Department of Biosciences & Nutrition, Karolinska Institutet, 141 83, Huddinge, Sweden.

Vladimir Gogvadze (V)

Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.

Yu-Zen Chen (YZ)

Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO, 80309, USA.

Ding Xue (D)

Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO, 80309, USA.

Sergio Moya (S)

CICbiomaGUNE, 20009, San Sebastian, Spain.

Jaime Ruiz (J)

ISM, UMR CNRS 5255, Université de Bordeaux, 33405, Talence, France.

Didier Astruc (D)

ISM, UMR CNRS 5255, Université de Bordeaux, 33405, Talence, France.

Roman Zubarev (R)

Department of Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.

Juha Kere (J)

Department of Biosciences & Nutrition, Karolinska Institutet, 141 83, Huddinge, Sweden.

Bengt Fadeel (B)

Nanosafety & Nanomedicine Laboratory, Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden. Bengt.Fadeel@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH